收稿日期: 2021-03-20
网络出版日期: 2022-06-28
基金资助
重庆市技术创新与应用发展专项面上项目(cstc2019jscx-msxmX0166)
杨聚荣, 林利容 . 慢性肾脏病患者妊娠的管理现状及策略[J]. 诊断学理论与实践, 2021 , 20(02) : 125 -129 . DOI: 10.16150/j.1671-2870.2021.02.002
| [1] | Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J]. Lancet, 2012, 379(9818):815-822. |
| [2] | Piccoli GB, Zakharova E, Attini R, et al. Pregnancy in chronic kidney disease: need for higher awareness. A pragmatic review focused on what could be improved in the different CKD stages and phases[J]. J Clin Med, 2018, 7(11):415. |
| [3] | Shahir AK, Briggs N, Katsoulis J, et al. An observational outcomes study from 1966-2008, examining pregnancy and neonatal outcomes from dialysed women using data from the ANZDATA Registry[J]. Nephrology (Carlton), 2013, 18(4):276-84. |
| [4] | Piccoli G, Bontempo S, Mezza E, et al. Sudden development of low tolerance of dialysis in a young female patient[J]. Nephrol Dial Transplant, 2004, 19(1):255-257. |
| [5] | Cabiddu G, Castellino S, Gernone G, et al. A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy[J]. J Nephrol, 2016, 29(3)277-303. |
| [6] | 南京总医院, 国家肾脏疾病临床医学研究中心. 慢性肾脏病患者妊娠管理指南[J]. 中华医学杂志, 2017, 97(46):3604-3612. |
| [7] | Masafumi F, Keitaro Y, Fumihiko K, et al. Clinical practice guideline for the management of chronic kidney disea-se-mineral and bone disorder[J/OL].(2012-05-23). https://cdn.jsn.or.jp/data/jsn-pregnancy.pdf. |
| [8] | de Castro I, Easterling TR, Bansal N, et al. Nephrotic syndrome in pregnancy poses risks with both maternal and fetal complications[J]. Kidney Int, 2017, 91(6):1464-1472. |
| [9] | Moroni G, Doria A, Giglio E, et al. Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study[J]. J Autoimmun, 2016, 74:194-200. |
| [10] | Fredi M, Lazzaroni MG, Tani C, et al. Systemic vasculitis and pregnancy: a multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies[J]. Autoimmun Rev, 2015, 14(8):686-691. |
| [11] | Buyon JP, Kim MY, Guerra MM, et al. Predictors of pregnancy outcomes in patients with lupus: a cohort study[J]. Ann Intern Med, 2015, 163(3):153-163. |
| [12] | Zhou H, Liu Y, Liu L, et al. Maternal pre-pregnancy risk factors for miscarriage from a prevention perspective: a cohort study in China[J]. Eur J Obstet Gynecol Reprod Biol, 2016, 206:57-63. |
| [13] | Nobles CJ, Mendola P, Mumford SL, et al. Pressure levels and reproductive outcomes in a prospective cohort of women attempting pregnancy[J]. Hypertension, 2018, 71(5):904-910. |
| [14] | Wiles K, Chappell L, Clark K, et al. Clinical practice guideline on pregnancy and renal disease[J]. BMC Nephrol, 2019, 31, 20(1):401. |
| [15] | Harel Z, McArthur E, Hladunewich M, et al. Serum creatinine levels before, during, and after pregnancy[J]. JAMA, 2019, 321(2):205-207. |
| [16] | Wiles K, Bramham K, Seed PT, et al. Serum creatinine in pregnancy: a systematic review[J]. Kidney Int Rep, 2018, 4(3):408-419. |
| [17] | Strevens H, Wide-Swensson D, Torffvit O, et al. Serum cystatin C for assessment of glomerular filtration rate in pregnant and non-pregnant women. Indications of altered filtration process in pregnancy[J]. Scand J Clin Lab Invest, 2002, 62(2):141-147. |
| [18] | Bramham K, Makanjuola D, Hussein W, et al. Serum cystatin is not a marker of glomerular filtration rate in pregnancy[J]. Obstet Med, 2009, 2(3):121-122. |
| [19] | Piccoli GB, Cabiddu G, Attini R, et al. Risk of adverse pregnancy outcomes in women with CKD[J]. J Am Soc Nephrol, 2015, 26(8):2011-2022. |
| [20] | Maynard SE, Thadhani R. Pregnancy and the kidney[J]. J Am Soc Nephrol, 2009, 20(1):14-22. |
| [21] | Waugh JJ, Bell SC, Kilby MD, et al. Optimal bedside urinalysis for the detection of proteinuria in hypertensive pregnancy: a study of diagnostic accuracy[J]. BJOG, 2005, 112(4):412-417. |
| [22] | Huang Q, Gao Y, Yu Y, et al. Urinary spot albumin:creatinine ratio for documenting proteinuria in women with preeclampsia[J]. Rev Obstet Gynecol, 2012, 5(1):9-15. |
| [23] | Waugh J, Hooper R, Lamb E, et al. Spot protein-creatinine ratio and spot albumin-creatinine ratio in the assessment of pre-eclampsia: a diagnostic accuracy study with decision-analytic model-based economic evaluation and acceptability analysis[J]. Health Technol Assess, 2017, 21(61):1-90. |
| [24] | Wiles K, Webster P, Seed PT, et al. The impact of chronic kidney disease stages 3-5 on pregnancy outcomes[J]. Nephrol Dial Transplant, 2020, 12:1-10. |
| [25] | 陈洪, 周春华. 慢性肾脏病与妊娠[J]. 中华肾病研究电子杂志, 2018, 7(6):225-228. |
| [26] | Piccoli GB, Daidola G, Attini R, et al. Kidney biopsy in pregnancy: evidence for counselling? A systematic narrative review[J]. BJOG, 2013, 120(4):412-427. |
| [27] | Magee LA, von Dadelszen P, Rey E, et al. Less-tight versus tight control of hypertension in pregnancy[J]. N Engl J Med, 2015, 372 (5):407-417. |
| [28] | 中华医学会妇产科学分会, 妊娠期高血压疾病学组. 妊娠期高血压疾病诊治指南(2020)[J]. 中华妇产科杂志, 2020, 55(4):227-238. |
| [29] | Brown MA, Magee LA, Kenny LC, et al. Hypertension in pregnancy(ISSHP). The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice[J]. Pregnancy Hypertens, 2018, 13:291-310. |
| [30] | Bateman BT, Patorno E, Desai RJ, et al. Angiotensin-converting enzyme inhibitors and the risk of congenital malformations[J]. Obstet Gynecol, 2017, 129(1):174-184. |
| [31] | Bateman BT, Patorno E, Desai RJ, et al. Late pregnancy β blocker exposure and risks of neonatal hypoglycemia and bradycardia[J]. Pediatrics, 2016, 138:e20160731. |
| [32] | Morgan JL, Kogutt BK, Meek C, et al. Pharmacokinetics of amlodipine besylate at delivery and during lactation[J]. Pregnancy Hypertens, 2018, 11:77-80. |
| [33] | Bergman JEH, Lutke LR, Gans ROB, et al. Beta-blocker use in pregnancy and risk of specific congenital anomalies: a european case-malformed control study[J]. Drug Saf, 2018, 41(4):415-427. |
| [34] | Hviid A, Mølgaard-Nielsen D. Corticosteroid use during pregnancy and risk of orofacial clefts[J]. CMAJ, 2011, 183(7):796-804. |
| [35] | Moroni G, Doria A, Giglio E, et al. Fetal outcome and recommendations of pregnancies in lupus nephritis in the 21st century. A prospective multicenter study[J]. J Autoimmun, 2016, 74:6-12. |
| [36] | Flint J, Panchal S, Hurrell A, et al. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-part Ⅰ: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids[J]. Rheumatology (Oxford), 2016, 55(9):1693-1697. |
| [37] | Chakkera HA, Kudva Y, Kaplan B. Calcineurin inhibitors: pharmacologic mechanisms impacting both insulin resistance and insulin secretion leading to glucose dysregulation and diabetes mellitus[J]. Clin Pharmacol Ther, 2017, 101(1):114-120. |
| [38] | Kim H, Jeong JC, Yang J, et al. The optimal therapy of calcineurin inhibitors for pregnancy in kidney transplantation[J]. Clin Transplant, 2015, 29(2):142-148. |
| [39] | Flint J, Panchal S, Hurrell A, et al. BSR and BHPR guideline on prescribing drugs in pregnancy and breast feeding-Part Ⅰ: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids[J]. Rheumatology(Oxford), 2016, 55(9):1693-1697. |
| [40] | Sanchez-Gonzalez LR, Castro-Melendez SE, Angeles-Torres AC, et al. Efficacy and safety of adjuvant recombinant human erythropoietin and ferrous sulfate as treatment for iron deficiency anemia during the third trimester of pregnancy[J]. Eur J Obstet Gynecol Reprod Biol, 2016, 205:32-36. |
| [41] | Tariq N, Ayub R, Khan WU, et al. Parenteral iron therapy in the treatment of iron deficiency anemia during pregnancy: a randomized controlled trial[J]. J Coll Physicians Surg Pak, 2015, 25(3):193-197. |
| [42] | Rolnik DL, Wright D, Poon LC, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia[J]. N Engl J Med, 2017, 377(7):613-622. |
| [43] | Wiles KS, Nelson-Piercy C, Bramham K. Reproductive health and pregnancy in women with chronic kidney disea-se[J]. Nat Rev Nephrol, 2018, 14(3):165-184. |
| [44] | van Dorp W, Mulder RL, Kremer LC, et al. Recommendations for premature ovarian insufficiency surveillance for female survivors of childhood, adolescent, and young adult cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup consortium[J]. J Clin Oncol 2016, 34(28): 3440-3450. |
| [45] | Donnez J, Dolmans MM. Fertility preservation in women[J]. N Engl J Med, 2017, 377(17):1657-1665. |
/
| 〈 |
|
〉 |
